World Journal of Experimental Medicine - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 819074

Number of visits today: 1163

Number of downloads: 643034

INDEXING/ABSTRACTING

MEMBERSHIP

BPG JOURNALS

Open-Access Journal

Other Issues: Previous | Next | Latest | Archive | Download full issue 4 (264)

Contents Volume 13 Issue 4 September 20, 2023

Review

Neurologic orphan diseases: Emerging innovations and role for genetic treatments

Ivelina P Kioutchoukova, Devon T Foster, Rajvi N Thakkar, Marco A Foreman, Brandon J Burgess, Rebecca M Toms, Eduardo E Molina Valero, Brandon Lucke-Wold

World J Exp Med 13(4):59-74. Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.59

Abstract (1058) | Core Tip (979) | Full Article (HTML) (3865) | Figures (1-5) (485) | Full Article (PDF)-2841K (259) | Full Article with Cover (PDF)-3034K (180) | Full Article (XML)-303K (106) | Audio-333K (4) | Peer-Review Report-234K (111) | Answering Reviewers-110K (124) | Received: 06/17/2023 | Revised: 07/16/2023 | Accepted: 08/11/2023 | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (5) | Total Visits (9246) | Similar Articles (0) | Timeline of Article Publication (4) | Authors Evaluation (2) | Article Quality Tracking (1) | What about the content of this article? (0) | Cite |

(0) | Open

Basic Study

Personalized clinical managements through exploring circulating neural cells and electroencephalography

Parvin Mehdipour, Nima Fathi, Masoud Nosratabadi

World J Exp Med 13(4):75-94. Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.75

Abstract (868) | Core Tip (966) | Article Highlights (943) | Full Article (HTML) (2407) | Figures (1-13) (441) | Tables (1-2) (417) | Full Article (PDF)-18536K (206) | Full Article with Cover (PDF)-18729K (162) | Full Article (XML)-148K (102) | Audio-2276K (8) | Peer-Review Report-245K (101) | Answering Reviewers-304K (106) | Received: 01/20/2023 | Revised: 05/22/2023 | Accepted: 07/11/2023 | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (0) | Total Visits (9428) | Similar Articles (3) | Timeline of Article Publication (3) | Authors Evaluation (1) | Article Quality Tracking (1) | What about the content of this article? (0) | Cite |

(0) | Open

Letter to the Editor

Ophthalmologic implications to consider when using hydroxychloroquine to treat COVID-19 and induced arthritis

Marco Zeppieri

World J Exp Med 13(4):95-98. Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.95

Abstract (1002) | Core Tip (922) | Full Article (HTML) (2337) | Full Article (PDF)-359K (146) | Full Article with Cover (PDF)-553K (133) | Full Article (XML)-43K (128) | Audio-345K (7) | Peer-Review Report-218K (102) | Answering Reviewers-111K (106) | Received: 04/21/2023 | Revised: 05/16/2023 | Accepted: 06/16/2023 | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (0) | Total Visits (7441) | Similar Articles (708) | Timeline of Article Publication (0) | Authors Evaluation (1) | Article Quality Tracking (2) | What about the content of this article? (0) | Cite |

(0) | Open

Update on hydroxychloroquine use in pregnancy

Wassan Nori, Nabeeha Najatee Akram, Raid M Al-Ani

World J Exp Med 13(4):99-101. Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.99

Abstract (1092) | Core Tip (1111) | Full Article (HTML) (3224) | Full Article (PDF)-351K (202) | Full Article with Cover (PDF)-545K (157) | Full Article (XML)-43K (117) | Audio-1788K (6) | Peer-Review Report-230K (103) | Answering Reviewers-85K (94) | Received: 04/13/2023 | Revised: 07/05/2023 | Accepted: 07/24/2023 | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (2) | Total Visits (8592) | Similar Articles (144) | Timeline of Article Publication (0) | Authors Evaluation (5) | Article Quality Tracking (2) | What about the content of this article? (0) | Cite |

(0) | Open

Write to the Help Desk

© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345